Larva Migrans: Management for the First Contact Physician and Review of the Current Literature

Main Article Content

María Cristina Ponce Figueroa
Susana González Hernández
Jaime Picazo Luna
Jacqueline Edith Mut Quej
Nayeli Guadalupe Gonzalez Bonilla

Abstract

Cutaneous larva migrans is a skin infection caused by the subcutaneous migration of larvae of different species of nematodes. Also called Creeping eruption or serpiginous eruption, it is an endemic skin parasitosis of tropical and subtropical areas with hot and humid climate. In our environment it is unusual, predominating in individuals who have come to these areas, although there are rare cases of acquisition in European countries. It was first described by Lee in 1874 and since then its prevalence has been increasing, affecting millions of people each year.


It is an endemic process in tropical and subtropical areas. Due to growing immigration and booming travel to these geographical areas, its prevalence in developed countries has increased in recent decades. For all these reasons, we believe it appropriate to disclose the existence of this parasitic dermatosis among dermatologists and primary care physicians.

Article Details

How to Cite
María Cristina Ponce Figueroa, Susana González Hernández, Jaime Picazo Luna, Jacqueline Edith Mut Quej, & Nayeli Guadalupe Gonzalez Bonilla. (2023). Larva Migrans: Management for the First Contact Physician and Review of the Current Literature. International Journal of Medical Science and Clinical Research Studies, 3(3), 309–311. https://doi.org/10.47191/ijmscrs/v3-i3-06
Section
Articles

References

I. Hengge UR. Cutaneous larva migrans. En: Tyring Stephen, Lupi O, Hengge U. Tropical Dermatology 2nd Edition. 2006. Elsevier, China: 74-76.

II. Bolognia J, Jorizzo J, Rapini R. Dermatology, 2nd ed. 2008 Elsevier, Spain: 1276-1282.

III. Heukelbach J, Feldmeier H. Epidemiological and clinical characteristics of hookworm related cutaneous larva migrans. Lancet Infect Dis. 2008; 8(5): 302-309.

IV. Becerra da Trinidade Neto, Azulay D, Azulay R. Dermatozoonosis. En: Azulay R, Azulay D, Azulay LA. Dermatología 4ta. Ed. 2007. Guanabara Koogan, Río de Janeiro: 433-434.

V. Hochedez P, Caumes E. Hookworm-related cutaneous larva migrans. J Travel Med. 2007; 14(5): 326-333.

VI. Langley R, Webb A, Haldane D, Purdy K, Walsh N. Confocal microscopy of cutaneous larva migrans. J Am Acad Dermatol. 2011; 64(1:Supl 1): AB 100.

VII. Weller, P. F. (2021, July 22). Hookworm-related cutaneous larva migrans. UpToDate. Retrieved January 13, 2023.

VIII. Bolognia J, Jorizzo J, Rapini R. Dermatology, 2nd ed. 2008 Elsevier, Spain: 1276-1282.

IX. Pinelli E, Herremans T, Harms MG, Hoek D, Kortbeek LM. Toxocara and Ascaris seropositivity among patients suspected of visceral and ocular larva migrans in the Netherlands: trends from 1998 to 2009. Eur J Clin Microbiol Infect Dis. 2011; 30(7): 873-879.

X. Dangoudoubiyam S, Kazacos KR. Differentiation of larva migrans caused by Baylisascaris procyonis and Toxocara species by Western blotting. Clin Vaccine Immunol. 2009; 16(11): 1563-1568.

XI. Infect Dangoudoubiyam S, Vemulapalli R, Ndao M, Kazacos KR. Recombinant antigenbased enzyme-linked immunosorbent assay for diagnosis of Baylisascaris procyonis larva migrans. Clin Vaccine Immunol. 2011; 18(10): 1650-1655.

XII. Gatcombe RR, Jothikumar N, Dangoudoubiyam S, Kazacos KR, Hill VR. Evaluation of a molecular beacon real-time PCR assay for detection of Baylisascaris procyonis in different soil types and water samples. Parasitol Res. 2010; 106(2): 499-504

XIII. De Ambrogi M, Aghzadeh M, Hermosilla C, Huber D, Majnaric D, Reljic S, Elson-Riggins J. Occurrence of Baylisascaris transfuga in wild populations of European brown bears (Ursus arctos) as identified by a new PCR method. Vet Parasitol. 2011; 179(1-3): 272-276.

XIV. Cutaneous Larva Migrans. (2023, 1 enero). ClinicalKey. Recuperado 18 de enero de 2023, de https://www.clinicalkey.es/

XV. Davies H.D., Sakuls P., Keystone J.S. Creeping eruption. A review of clinical presentation and management of 60 cases presenting to a tropical disease unit. Arch. Dermatol. 1993; 129(5): 588-591.

XVI. Leonardi D, Echenique C, Lamas MC, Salomon CJ. High efficacy of albendazole-PEG 6000 in the treatment of Toxocara canis larva migrans infection. J Antimicrob Chemother. 2009; 64(2): 375-378.

XVII. Barrera MG, Leonardi D, Bolmaro RE, Echenique CG, Olivieri AC et al. In vivo evaluation of albendazole microspheres for the treatment of Toxocara canis larva migrans. Eur J Pharm Biopharm. 2010; 75(3): 451-454.

XVIII. Feldmeier H. Tungiasis and cutaneous larva migrans: unpleasant travel souvenirs. Med Monatsschr Pharm. 2009; 32(12): 440-444.

Most read articles by the same author(s)